A Medical Device Daily
Lifeline Biotechnologies, (Reno, Nevada) reported that it has filed the patent application on its new neural network diagnostic system. As previously reported, Lifeline has been working with an Asian university to enhance the company's First Warning System; this patent application is the result of that work, it said.
According to Dr. Louis Keith, emeritus professor of obstetrics and gynecology at the Feinberg School of Medicine at Northwestern University (Evanston, Illinois), "We can now determine which of the thermal aberrations the First Warning System detects is similar to those associated with known cancers. Using a combination of five neural network constructions, we have broken this illusive barrier. This new system has the ability to provide us with 100% selectivity, finding all areas in the breast which generate abnormal thermal signals and, with specificity in the low nineties, correctly classifying them in terms of their similarity to signals obtained from patients with known cancers. This system will continue to improve in its accuracy over time because it learns from each new case presented to it."
Lifeline is focused on completing the development of the First Warning System, designed to assist in the early detection of breast cancer.